| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.23 | 0.0004 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |